Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label single-arm study of topical abafungin absorption in interdigital tinea pedis
2007-002112-26Phase 3Completed
- Sponsor
- York Pharma
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of abafungin in interdigital tinea pedis (TP), sponsored by York Pharma. Primary endpoint: Pharmacokinetic parameters. Started Apr 2007; status: completed.
02
Drugs
abafungin
03
Conditions
interdigital tinea pedis (TP)
Beyond the preview
Go deeper on 2007-002112-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002112-26.